Pharmaceutical contract services round-up
In a round-up of motley pharmaceutical services contracts, Outsourcing-Pharma takes a look at recent news involving United Drug, Movianto and IBM.
In a round-up of motley pharmaceutical services contracts, Outsourcing-Pharma takes a look at recent news involving United Drug, Movianto and IBM.
The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse this wealth of data.
Two French contract research organisations (CROs) that specialise in ophthalmology have banded together to offer specialised services to this niche market.
Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride.
Harvard Bioscience has rejected an unsolicited acquisition offer from Skystone Advisors to acquire all outstanding shares of common stock in the life science tools and instrument manufacturer.
Eli Lilly has handed over the manufacturing reins of the antibiotic Seromycin to the Chao Centre for Industrial Pharmacy and Contract Manufacturing.